BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen C, Wu Z, Wang Y, Gao S, Da, Xie L, Qie Y, Tian D, Hu H. Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients. Cancer Med 2020;9:3885-903. [PMID: 32250047 DOI: 10.1002/cam4.3006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Li Z, Wang Z, Yang S, Shen C, Zhang Y, Jiang R, Zhang Z, Zhang Y, Hu H. CircSTK39 suppresses the proliferation and invasion of bladder cancer by regulating the miR-135a-5p/NR3C2-mediated epithelial-mesenchymal transition signaling pathway. Cell Biol Toxicol 2022. [DOI: 10.1007/s10565-022-09785-3] [Reference Citation Analysis]
2 Wang Y, Tang S, Li L, Sun C, Liu Y, Zhao Y. Depletion of circPDSS1 inhibits ITGA11 production to confer cisplatin sensitivity through miR-515-5p in gastric cancer. Journal of Chemotherapy 2022. [DOI: 10.1080/1120009x.2022.2151702] [Reference Citation Analysis]
3 Hashemi M, Arani HZ, Orouei S, Rostamnejad E, Ghorbani A, Khaledabadi M, Kakavand A, Tavakolpournegari A, Saebfar H, Heidari H, Salimimoghadam S, Taheriazam A, Entezari M, Khan H. Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions. Pharmacological Research 2022;185:106475. [DOI: 10.1016/j.phrs.2022.106475] [Reference Citation Analysis]
4 Shen C, Li Z, Zhang Y, Zhang Z, Wu Z, Da L, Yang S, Wang Z, Zhang Y, Qie Y, Zhao G, Lin Y, Huang S, Zhou M, Hu H. Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer. Front Oncol 2022;12:1018285. [DOI: 10.3389/fonc.2022.1018285] [Reference Citation Analysis]
5 Zhou L, Chen W, Yang H, Liu J, Meng H, Li S. Calycosin Inhibits the Malignant Behaviors of Lung Adenocarcinoma Cells by Regulating the circ_0001946/miR-21/GPD1L/HIF-1α Signaling Axis. Disease Markers 2022;2022:1-18. [DOI: 10.1155/2022/3969389] [Reference Citation Analysis]
6 Xue C, Li G, Zheng Q, Gu X, Bao Z, Lu J, Li L. The functional roles of the circRNA/Wnt axis in cancer. Mol Cancer 2022;21:108. [PMID: 35513849 DOI: 10.1186/s12943-022-01582-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Qu X, Tao J, Xie J. Circ_0009035 regulates the progression of cervical cancer by targeting miR-1305/CREBRF axis. Anticancer Drugs 2022. [PMID: 35389936 DOI: 10.1097/CAD.0000000000001278] [Reference Citation Analysis]
8 Ghafouri-fard S, Najafi S, Hussen BM, Basiri A, Hidayat HJ, Taheri M, Rashnoo F. The Role of Circular RNAs in the Carcinogenesis of Bladder Cancer. Front Oncol 2022;12:801842. [DOI: 10.3389/fonc.2022.801842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Chen R, Liang F, Yan J, Wang Y. CircCDK17 knockdown inhibits tumor progression and cell glycolysis by downregulaing YWHAZ expression through sponging miR-1294 in cervical cancer. J Ovarian Res 2022;15:24. [PMID: 35168653 DOI: 10.1186/s13048-022-00952-y] [Reference Citation Analysis]
10 Zhu K, Liu X, Deng W, Wang G, Fu B. Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer. Hereditas 2022;159. [DOI: 10.1186/s41065-021-00212-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Jiang Z, Hu H, Hu W, Hou Z, Liu W, Yu Z, Liang Z, Chen S. Circ-RNF121 regulates tumor progression and glucose metabolism by miR-1224-5p/FOXM1 axis in colorectal cancer. Cancer Cell Int 2021;21:596. [PMID: 34742305 DOI: 10.1186/s12935-021-02290-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Amuti A, Liu D, Maimaiti A, Yu Y, Yasen Y, Ma H, Li R, Deng S, Pang F, Tian Y. Doxorubicin inhibits osteosarcoma progression by regulating circ_0000006/miR-646/ BDNF axis. J Orthop Surg Res 2021;16:645. [PMID: 34717683 DOI: 10.1186/s13018-021-02782-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Sun K, Wang D, Yang BB, Ma J. The Emerging Functions of Circular RNAs in Bladder Cancer. Cancers (Basel) 2021;13:4618. [PMID: 34572845 DOI: 10.3390/cancers13184618] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Mirzaei S, Paskeh MDA, Hashemi F, Zabolian A, Hashemi M, Entezari M, Tabari T, Ashrafizadeh M, Raee P, Aghamiri S, Aref AR, Leong HC, Kumar AP, Samarghandian S, Zarrabi A, Hushmandi K. Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies. Life Sci 2021;:119948. [PMID: 34520771 DOI: 10.1016/j.lfs.2021.119948] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
15 Zhang Z, Sang Y, Liu Z, Shao J. Negative Correlation Between Circular RNA SMARC5 and MicroRNA 432, and Their Clinical Implications in Bladder Cancer Patients. Technol Cancer Res Treat 2021;20:15330338211039110. [PMID: 34482767 DOI: 10.1177/15330338211039110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Cheng F, Zheng B, Si S, Wang J, Zhao G, Yao Z, Niu Z, He W. The Roles of CircRNAs in Bladder Cancer: Biomarkers, Tumorigenesis Drivers, and Therapeutic Targets. Front Cell Dev Biol 2021;9:666863. [PMID: 34350174 DOI: 10.3389/fcell.2021.666863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
17 Zhang M, Wen F, Zhao K. Circular RNA_0001946 is insufficiently expressed in tumor tissues, while its higher expression correlates with less lymph node metastasis, lower TNM stage, and improved prognosis in NSCLC patients. J Clin Lab Anal 2021;35:e23625. [PMID: 34216509 DOI: 10.1002/jcla.23625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Chen F, He L, Qiu L, Zhou Y, Li Z, Chen G, Xin F, Dong X, Xu H, Wang G, Liu J, Cai Z. Circular RNA CircEPB41L2 Functions as Tumor Suppressor in Hepatocellular Carcinoma Through Sponging miR-590-5p. Cancer Manag Res 2021;13:2969-81. [PMID: 33833580 DOI: 10.2147/CMAR.S291682] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
19 Cong S, Li J, Zhang J, Feng J, Zhang A, Pan L, Ma J. Construction of circRNA-miRNA-mRNA Network for Exploring Underlying Mechanisms of Lubrication Disorder. Front Cell Dev Biol 2021;9:580834. [PMID: 33777926 DOI: 10.3389/fcell.2021.580834] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Yang L, Zou X, Zou J, Zhang G. Functions of circular RNAs in bladder, prostate and renal cell cancer (Review). Mol Med Rep 2021;23:307. [PMID: 33649838 DOI: 10.3892/mmr.2021.11946] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
21 Liang Z, Guo W, Fang S, Zhang Y, Lu L, Xu W, Qian H. CircRNAs: Emerging Bladder Cancer Biomarkers and Targets. Front Oncol 2020;10:606485. [PMID: 33489913 DOI: 10.3389/fonc.2020.606485] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Cai Z, Li H. Circular RNAs and Bladder Cancer. Onco Targets Ther 2020;13:9573-86. [PMID: 33061440 DOI: 10.2147/OTT.S268859] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
23 Shen C, Wu Z, Wang Y, Gao S, Da, Xie L, Qie Y, Tian D, Hu H. Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients. Cancer Med 2020;9:3885-903. [PMID: 32250047 DOI: 10.1002/cam4.3006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]